{"certainAgreement":{"otherDetails":"PI can publish after first multi-site publication or if no multi-site publication is made within 18 months of study completion/termination. The only disclosure restriction on PI is sponsor can review results comms. prior to public release and can embargo comms. regarding trial results for a period \\>60 but ≤180 days from time submitted to sponsor review. Sponsor can't require changes to the comms, extend embargo or require changes to comms, except removing confidential info that are not results","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"clinical.trials@adctherapeutics.com","organization":"ADC Therapeutics SA","phone":"954-903-7994","phoneExt":"954","title":"Clinical Trials Information"}}